Insider Trading & Ownership - Doebele Robert

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Doebele Robert

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-01-26
Disposition
2024-01-26
4:36 pm
N/A
N/A
Rain Oncology Inc.RAINDoebele Robert
See Remarks
474,436$00
(Direct)
View
2024-01-26
Equity Swap
2024-01-26
4:36 pm
N/A
N/A
Rain Oncology Inc.RAINDoebele Robert
See Remarks
476,827$00
(Direct)
View
2023-08-09
Option Award
2023-08-11
9:16 pm
N/A
2033-08-09
Rain Oncology Inc.RAINDoebele Robert
See Remarks
149,100$0149,100
(Direct)
View
2023-02-15
Option Award
2023-02-17
6:18 pm
N/A
2033-02-15
Rain Oncology Inc.RAINDoebele Robert
See Remarks
123,325$0123,325
(Direct)
View
2022-07-06
Exercise
2022-07-07
6:02 pm
N/A
2029-03-13
Rain Therapeutics Inc.RAINDoebele Robert
See Remarks
3,890$0481,827
(Direct)
View
2022-07-06
Exercise
2022-07-07
6:02 pm
N/A
N/A
Rain Therapeutics Inc.RAINDoebele Robert
See Remarks
3,890$3.95481,827
(Direct)
View
2022-04-13
Exercise
2022-04-15
4:30 pm
N/A
2029-03-13
Rain Therapeutics Inc.RAINDoebele Robert
See Remarks
3,000$0481,827
(Direct)
View
2022-04-13
Exercise
2022-04-15
4:30 pm
N/A
N/A
Rain Therapeutics Inc.RAINDoebele Robert
See Remarks
3,000$3.95481,827
(Direct)
View
2022-03-31
Exercise
2022-04-04
4:15 pm
N/A
2029-03-13
Rain Therapeutics Inc.RAINDoebele Robert
See Remarks
2,000$0481,827
(Direct)
View
2022-03-31
Exercise
2022-04-04
4:15 pm
N/A
N/A
Rain Therapeutics Inc.RAINDoebele Robert
See Remarks
2,000$3.95481,827
(Direct)
View
2022-01-07
Option Award
2022-02-04
4:35 pm
N/A
2032-01-07
Rain Therapeutics Inc.RAINDoebele Robert
EVP, Chief Scientific Officer
72,000$072,000
(Direct)
View
2021-04-27
Conversion
2021-04-27
5:04 pm
N/A
N/A
Rain Therapeutics Inc.RAINDoebele Robert
EVP, Chief Scientific Officer
10,259$0467,937
(Direct)
View

Ownership
2021-04-22
7:12 pm
N/A
N/A
Rain Therapeutics Inc.RAINDoebele Robert
EVP, Chief Scientific Officer
0$0606,838
(Direct)
View